News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
More than 36 million Americans have type 2 diabetes, meaning their blood sugar levels are always top of mind. After all, when ...
Over time, untreated high blood sugar can lead to serious and even life threatening complications. Type 2 diabetes also puts you at risk for certain health conditions that can reduce life ...
Certain additives found in ultra-processed foods are linked to increased type 2 diabetes risk, a new study finds. The mixtures are typically present in broths, dairy desserts, fats, sauces, and sugary ...
In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.
Medical experts have officially recognised a lesser-known diabetes, known as Type 5 diabetes. The condition is common among ...
The new name and endorsement at the World Diabetes Congress are seen as long-overdue recognition that will spur more research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback